Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
As of today, Abbott(ABT) shares are valued at $92.07. The company's market cap stands at 160.95B, with a P/E ratio of 26.74 and a dividend yield of 2.5%.
On 2026-04-24, Abbott(ABT) stock moved within a range of $90.72 to $92.48. With shares now at $92.07, the stock is trading +1.5% above its intraday low and -0.4% below the session's peak.
Trading volume for Abbott(ABT) stock has reached 13.01M, versus its average volume of 14.44M.
The stock's 52-week range extends from a low of $90.72 to a high of $139.06.
The stock's 52-week range extends from a low of $90.72 to a high of $139.06.
ABT News
Abbott Laboratories (NYSE:ABT) received an AACR award for multi year outcomes from the DETECT A trial using its Cancerguard multi cancer early detection test....
Daiwa downgraded Abbott (ABT) to Neutral from Outperform with a price target of $92, down from $113. Unlock hedge fund-level data and powerful investing tools...
Earlier in April 2026, Abbott Laboratories reported first-quarter sales of US$11.16 billion but lower net income of US$1.08 billion, while also facing a US$70 m...
Analyst ratings
75%
of 32 ratingsMore ABT News
Key Points Abbott Laboratories and Dexcom are the biggest players in the market for continuous glucose monitoring devices. Abbott has a vast lineup of product...
The stock market has been a volatile place over the past few months, with the S&P 500 shifting from gains to losses. The market didn't exactly crash, but at cer...
Advertisement Why Abbott Laboratories (ABT) is on investors’ radar Abbott Laboratories (ABT) is drawing attention after a period of weaker share performance,...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Abbott (ABT) announced it will present new data at the American Association for Cancer Research Annual Meeting 2026 demonstrating continued advancements in its...
The stock of Abbott Laboratories (ABT) has been hit with multiple downgrades from Wall Street analysts after the company’s latest financial results. Unlock hed...
Shares of Abbott Laboratories (NYSE:ABT) rose in early trading on Friday, after tanking around 6% on Thursday following the company's first-quarter results. Th...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.